Core Viewpoint - Walgreens Boots Alliance is experiencing a potential acquisition interest, which has led to a rise in its stock price amid ongoing struggles and challenges faced by the company [1][2][4]. Group 1: Company Performance - Walgreens has been struggling for years, facing issues such as overpayment in the acquisition of VillageMD urgent care centers, opioid lawsuits, and a slowdown in COVID vaccine sales [2]. - The company's market capitalization has fallen to approximately $9.3 billion, making it a potentially attractive acquisition target due to its assets, which include around 10,000 stores in the U.S. [2]. - Despite some signs of recovery with growth in sales and adjusted earnings per share, Walgreens continues to face significant challenges [4]. Group 2: Acquisition Interest - There have been reports of interest from private equity firm Sycamore in acquiring Walgreens, although the likelihood of a deal remains uncertain [3]. - Recent comments from CNBC's David Faber have sparked optimism among investors regarding a potential deal, contributing to a 10.2% increase in stock price [1][3]. - The buyout price from Sycamore is currently unclear, but ongoing rumors are expected to influence Walgreens' stock movement [4].

As per a media report in December, Walgreens Boots Alliance Inc WBA suggested the company is in talks to be acquired by Sycamore Partners.Walgreens's market value has shrunk from over $100 billion a decade ago to around $8.4 billion, as per data from Benzinga Pro.Earlier on Tuesday, citing CNBC, the Bloomberg report noted that the take-private deal with the private equity firm is still possible.Walgreens Boots Alliance' deal appeared "mostly dead a couple of weeks ago," CNBC's David Faber said Tuesday. He s ...

Walgreens Boots Alliance (WBA) , already dealing with a range of challenges, is set to face further market pressures after Moody’s Ratings downgraded its outlook from stable to negative last Friday. The downgrade highlights significant risks tied to the company’s multi-year operational turnaround strategy. The shift comes as the company continues to face a weaker consumer environment, growing inflation and reimbursement rate pressures, along with challenges from legal disputes and dark rent from its planned ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Walgreens Boots Alliance, Inc. common stock between April 2, 2020, and January 16, 2025, of the March 31, 2025, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Walgreens common stock during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the Court by March 31, 2025, representing other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 and has been consistently ranked among the top firms for securities class action settlements since 2013 [4]. Group 3: Case Allegations - The lawsuit alleges that Walgreens failed to disclose widespread violations of federal law regarding prescription medication dispensation and reimbursement during the Class Period [5]. - It claims that Walgreens' conduct posed a risk of regulatory scrutiny, civil liability, and reputational harm, and that the company's public statements were materially false and misleading [5].

SAN DIEGO, Feb. 14, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) common stock between April 2, 2020 and January 16, 2025, all dates inclusive (the "Class Period"), have until March 31, 2025 to seek appointment as lead plaintiff of the Walgreens class action lawsuit. Captioned Klein v. Walgreens Boots Alliance, Inc., No. 25-cv-01058 (N.D. Ill.), the Walgreens class action lawsuit charges Walgreens as well as certa ...

The most recent trading session ended with Walgreens Boots Alliance (WBA) standing at $9.70, reflecting a -0.51% shift from the previouse trading day's closing. This change lagged the S&P 500's daily loss of 0.01%. At the same time, the Dow lost 0.37%, and the tech-heavy Nasdaq gained 0.41%.Shares of the largest U.S. drugstore chain have depreciated by 24.59% over the course of the past month, underperforming the Retail-Wholesale sector's gain of 9.64% and the S&P 500's gain of 4.88%.The upcoming earnings r ...

NEW YORK, Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Walgreens investors who were adversely affected by alleged securities fraud between April 2, 2020 and January 16, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/walgreens-boots-a ...

Walgreens Boots Alliance has hired a firm to sell its stake in doctor-staffed clinic operator ... [+] VillageMD, which has already cost the drugstore giant billions of dollars.Walgreens Boots Alliance Walgreens Boots Alliance is getting closer to selling its stake in doctor-staffed clinic operator VillageMD, which has already cost the drugstore giant billions of dollars.Walgreens is working with the investment banking firm Evercore and the consulting firm Alvarez & Marsal as advisors in the sale, several ne ...

NEW YORK, Feb. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA).Shareholders who purchased shares of WBA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form-2/?id=128954&from=4 CLASS ...

Walgreens Boots Alliance-backed healthcare clinic chain VillageMD is reportedly working with advisers to explore a sale, restructuring or other options.This move comes after Walgreens CEO Tim Wentworth said during a January earnings call that the company plans to divest VillageMD, Bloomberg reported Wednesday (Feb. 12).A Walgreens spokesperson told Bloomberg that Walgreens “is continuing to work toward executing its stated goal of securing an endpoint for its investment in VillageMD, consistent with Walgree ...